BLU-451

· Blueprint Medicines Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLU-451, covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations [Phase 1]